Compare AbCellera Biologics Inc (ABCL) vs Cadence Design Systems Inc (CDNS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs Cadence Design Systems Inc — how do they compare? AbCellera Biologics Inc trades at $7.13 (market cap $2.35B), while Cadence Design Systems Inc trades at $372.68 (market cap $102.34B). The key difference: Cadence Design Systems Inc is far larger — about 43.5× AbCellera Biologics Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Cadence Design Systems Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | CDNS | |
|---|---|---|
Market Cap | $2.35B | $102.34B |
Sector | Health | Technology |
52-Week High | $8.12 | $416.39 |
52-Week Low | $2.78 | $265.66 |
Enterprise Value | $1.99B | $104.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbCellera Biologics (ABCL) trades at $7.69, down 5.18% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported a net loss of -$146.41M in 2025, with negative margins, though revenue grew to $75.13M. Recent news highlights a major collaboration with Jazz Pharmaceuticals worth up to $876M, potentially boosting future revenue streams. Analyst consensus is strongly bullish with a $9.67 price target, indicating 25.7% upside.
The outlook hinges on execution of new partnerships and pipeline progress, particularly ABCL635 Phase 2 data expected in Q3 2026. Key risks include persistent cash burn, high valuation multiples despite losses, and biotech sector volatility. Investors should weigh the strong analyst support against fundamental challenges and the stock's current technical overbought condition.
Cadence Design Systems (CDNS) trades at $371.06, down 0.56% on the day, with strong analyst support showing 84% buy ratings and a $395.88 consensus price target. The stock demonstrates robust fundamentals with consistent earnings beats, 86% gross margins, and 21% net income margins. Recent technical analysis shows neutral momentum with support at $370 and resistance at $380. The company benefits from AI-driven semiconductor design demand and recently announced expanded collaboration with Intel Foundry.
CDNS presents a compelling growth story with strong profitability and market positioning in EDA software. The primary investment thesis centers on sustained AI-driven demand for chip design tools, though elevated valuation multiples (P/E 87.6) require continued execution. Key risks include semiconductor cycle volatility and competitive pressures from Synopsys. Upside potential exists if the company maintains its earnings beat streak and capitalizes on AI infrastructure spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Cadence Design Systems Inc
Cadence Design Systems is a provider of electronic design automation software, intellectual property, and system design and analysis products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Cadence offers a portfolio of design IP, as well as system design and analysis products, which enable system-level analysis and verification solutions. Cadence's comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers, alongside secular digitalization of various end markets, benefits EDA vendors like Cadence.
Read more on CDNS →
